SCHEMBL19909329

SCHEMBL19909329

N#Cc1cc(-n2c3ccc(C(F)(F)F)cc3c3cc(C(F)(F)F)ccc32)c(-c2ccncc2)c(-n2c3ccc(C(F)(F)F)cc3c3cc(C(F)(F)F)ccc32)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.40
MAPK14 Q16539 2/20 0.38
CSNK1A1 P48729 1/20 0.37
CSNK1D P48730 1/20 0.37
CYP19A1 P11511 1/20 0.36
CYP3A4 P08684 2/20 0.36
CYP3A5 P20815 2/20 0.36
RIPK3 Q9Y572 1/20 0.35
HRH1 P35367 1/20 0.35
HTR6 P50406 1/20 0.35
DGAT1 O75907 1/20 0.34
SOAT1 P35610 1/20 0.34
KCNH2 Q12809 1/20 0.34
MAT2A P31153 1/20 0.34
SRC P12931 1/20 0.33
BRAF P15056 1/20 0.33
KDR P35968 1/20 0.33
CHUK O15111 1/20 0.33
ABL1 P00519 1/20 0.33
BCR P11274 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19908948 0.94 KIF11 (0.37) KIF11MAPK14CSNK1A1CSNK1DCYP19A1
SCHEMBL19913157 0.93 KIF11 (0.37) KIF11MAPK14CSNK1A1CSNK1DCYP19A1
SCHEMBL19919749 0.90 KIF11 (0.40) KIF11MAPK14CSNK1A1CSNK1DCYP19A1
SCHEMBL19913142 0.89 KIF11 (0.40) KIF11MAPK14CSNK1A1CSNK1DCYP19A1
SCHEMBL19913149 0.89 KIF11 (0.36) KIF11MAPK14CSNK1A1CSNK1DCYP3A4
SCHEMBL19909109 0.89 RXRA (0.39) KIF11MAPK14CSNK1A1CSNK1DRIPK3
SCHEMBL19909340 0.88 ALOX5AP (0.36) KIF11MAPK14CSNK1A1CSNK1DCYP3A4
SCHEMBL19908947 0.88 KIF11 (0.42) KIF11MAPK14CSNK1A1CSNK1DCYP19A1
SCHEMBL21414244 0.87 KIF11 (0.41) KIF11CYP19A1CYP3A4DGAT1SOAT1
SCHEMBL22564397 0.86 RXRA (0.41) KIF11CYP3A4DGAT1SOAT1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 KIF11 3067/4885MAPK14 2544/4885CSNK1A1 4231/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 KIF11 3082/4885MAPK14 2787/4885CSNK1A1 2962/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 KIF11 3067/4885MAPK14 2544/4885CSNK1A1 4231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.